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Abstract
Diabetic nephropathy is a serious complication of longstanding diabetes and its pathogenesis remains unclear. Oxidative
stress may play a critical role in the pathogenesis and progression of diabetic nephropathy. Our previous studies have
demonstrated that polyunsaturated fatty acids (PUFA) induce peroxynitrite generation in primary human kidney mesangial
cells and heat shock protein 90b1 (hsp90b1) is indispensable for the PUFA action. Here we investigated the effects of high
fat diet (HFD) on kidney function and structure of db/db mice, a widely used rodent model of type 2 diabetes. Our results
indicated that HFD dramatically increased the 24 h-urine output and worsened albuminuria in db/db mice. Discontinuation
of HFD reversed the exacerbated albuminuria but not the increased urine output. Prolonged HFD feeding resulted in early
death of db/db mice, which was associated with oliguria and anuria. Treatment with the geldanamycin derivative, 17-
(dimethylaminoehtylamino)-17-demethoxygeldanamycin (17-DMAG), an hsp90 inhibitor, preserved kidney function, and
ameliorated glomerular and tubular damage by HFD. 17-DMAG also significantly extended survival of the animals and
protected them from the high mortality associated with renal failure. The benefit effect of 17-DMAG on renal function and
structure was associated with a decreased level of kidney nitrotyrosine and a diminished kidney mitochondrial Ca
2+ efflux in
HFD-fed db/db mice. These results suggest that hsp90b1 is a potential target for the treatment of nephropathy and renal
failure in diabetes.
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Introduction
Diabetic nephropathy is a progressive disorder in diabetic
patients and worsens over time. Although hyperglycemia is
known as the primary factor underlying the initiation and
progression of diabetic nephropathy, the pathogenesis of diabetic
nephropathy is complex and remains unclear [1]. Oxidative
stress due to increased reactive oxygen species (ROS) production
has been postulated to contribute to matrix accumulation,
inflammation and tubulointerstitial fibrosis in the diabetic kidney
[2–4]. Peroxynitrite, formed by the interaction of superoxide
and nitric oxide, is a potent oxidant that attacks a variety of
biomolecules including proteins, and causes structural and
functional damage to tissues and cells. Increased level of
nitrotyrosine in proximal tubules of diabetic patients suggest
that oxidative injury of the proximal tubules by peroxynitrite
may play an important part in the pathogenesis and/or
progression of diabetic nephropathy [5]. Improvement of
glomerular filtration rate in type 2 diabetes patients with
diminished kidney functions by bardoxolone methyl, an agonist
of nuclear factor-erythroid 2-related factor 2 that regulates
cytoprotective antioxidant pathways, demonstrated the efficacy
of antioxidant in treating diabetic nephropathy [6,7].
Longstanding hyperglycemia, along with other factors, is
associated with accelerated decline of kidney function in patients
with type 2 diabetic nephropathy [8]. Despite the lack of benefits
for all-cause mortality and cardiovascular mortality, intensive
hyperglycemic control reduces the risk of diabetic nephropathy
and other microvascular complications significantly [9]. In vitro
studies also support the critical role of high glucose in regulating
matrix protein levels in kidney cells including mesangial [10],
endothelial and epithelial cells [11]. Hyperglycemia exposure,
albuminuria and other factors interact with the tubular system to
cause oxidative stress and interstitial inflammation, which in turn
contribute to tubulointerstitial fibrosis and progression of diabetic
nephropathy [2,12]. Exposure of primary human renal proximal
tubular cells to high glucose enhances cell proliferation and
increases the level of collagen IV and fibronectin [13,14].
Increased collagen IV expression, mitochondrial dysfunction and
excessive ROS generation were observed in murine proximal
tubular cells exposed to high glucose [15–17].
Despite the critical role of hyperglycemia per se in vascular
complications of type 2 diabetes, other metabolic factors, such as
hyperlipidemia and elevated serum nonesterified fatty acids
(NEFA), are clearly involved in the pathogenesis of diabetic
nephropathy. Excessive NEFA not only contribute to insulin
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mitochondrial defects [23]. Our previous studies indicate that
polyunsaturated fatty acids (PUFA) induce peroxynitrite genera-
tion in various cell types including primary human mesangial cells
[24,25]. The increasing peroxynitrite formation in response to
PUFA requires heat shock protein 90b1 (HSP90b1) and is
associated with Ca
2+ efflux from the mitochondria [25,26]. In
the current work, we investigated the role of hsp90 in high fat diet
(HFD)-induced renal failure in db/db mice. Our results demon-
strated that inhibition of hsp90 with 17-DMAG preserved kidney
function, ameliorated glomerular and tubular damage, and
improved animal survival in HFD- fed db/db mice. These
beneficial effects of 17-DMAG in vivo may result from a reduction
of peroxynitrite formation and oxidative damage in the kidney of
db/db mice. Our findings provide new insights into molecular
mechanisms underlying diabetic nephropathy.
Results
High fat diet (HFD) induces decline of kidney function in
db/db mice
In these experiments, the challenge of db/db mice with HFD
was divided into two phases with a four-week regular diet (RD)
interval as illustrated in Figure 1A. This design allowed us to test
the effect of HFD on kidney function in db/db mice and whether
the HFD effects were reversible. Following the first phase of HFD
feeding (on HFD for 2 weeks starting at 3 month old), all db/db
mice showed dramatic increases in urinary albumin excretion and
urine output (Figure 1 B and C), rapid bodyweight gain, and
elevated blood glucose levels (Figure S1). The urinary albumin
excretion (Figure 1 B) and bodyweight (Figure S1) were fully
reversed to the pre-HFD treatment levels following discontinua-
tion of HFD for four weeks. However, the increased urine output
and blood glucose levels induced by HFD feeding persisted at four
weeks following discontinuation of HFD. In parallel control
experiments, two-week HFD challenge had no significant effects
on urinary albumin excretion and urine output in the non-diabetic
heterozygous littermate db/+ mice (Figure 1 B and C).
The hsp90 inhibitor 17-DMAG antagonizes HFD-induced
decline of kidney functions in db/db mice
Feeding db/db mice with HFD leads to rapid and reversible
bodyweight gain because of the increase in fat tissues, which may
further exacerbate circulating fatty acids, including PUFA.
Linoleic acid (LA), a major component of PUFA in the plasma,
interacts with hsp90b1 to cause mitochondrial Ca
2+ ([Ca
2+]m)
efflux and peroxynitrite generation in cell cultures [25,26]. These
pathways may contribute to HFD-induced decline of kidney
functions in db/db mice by increasing oxidative stress. In the
second phase of HFD challenge (Figure 1), db/db mice were
treated with or without 17-DMAG (6.5 mg/kg bodyweight injected
intraperitoneally once daily) to test the involvement of hsp90. The
dose of 17-DMAG was chosen based on our previous studies
showing 17-DMAG at that concentration exerting maximal
inhibition on PUFA-induced [Ca
2+]m efflux but not producing
apparent toxicity to cells [26]. In db/db mice without 17-DMAG
treatment [injected with saline (vehicle) db/db-HF-S group, Figure 1
D], a dramatic increase in urine albumin excretion was observed
following two weeks on HFD in the second phase of HFD
challenge, mirroring the results in the first phase of HFD feeding
(Figure 1B). Interestingly, treatment with 17-DMAG of the db/db
mice during the second phase of HFD challenge significantly
reduced albuminuria (db/db-HF-G group, Figure 1 D).
In contrast to the large increase of 24-h urine volume during
two weeks of the first phase of HFD feeding, there was only a small
and insignificant decrease of 24-h urine output following initial
two weeks on HFD in the second phase (Figure 1E). Interestingly,
starting from the 17
th day of the second phase of HFD feeding, we
observed a dramatic decrease of urine output or development of
anuria in saline-injected db/db mice (db/db-HF-S group, Figure 1
E), indicating the loss of kidney function and the development of
renal failure. Treatment with 17-DMAG resulted in significantly
higher 24 h urine output (db/db-HF-G group, Figure 1 E),
indicating preservation of renal function and prevent of renal
failure by 17-DMAG. These beneficial effects of 17-DMAG on
kidney functions were observed without measurable changes in
blood glucose compared with that of saline-injected animals (db/
db-HF-S vs db/db-HF-G, Figure 1 F).
The induction of renal failure by prolonged HFD feeding in db/
db mice and the beneficial effect of 17-DMAG treatment were
further supported by evidence based on serum creatinine
measurement. Serum creatinine was determined in animals at
the end of four weeks of the second phase HFD feeding. The
results indicated that the serum creatinine was 283% higher in
saline-injected db/db mice compared to db/+ mice (db/db-HF-S vs
db/+, Figure 1G). Interestingly, treatment with 17-DMAG
significantly lowered the serum creatinine in HFD-fed db/db
mice (db/db-HF-G vs db/db-HF-S, Figure 1G) and no significant
difference was found between db/db-HF-G and db/+ groups,
indicating that 17-DMAG restored mice kidney function to
normal creatinine clearance. These data provided evidence that
HFD feeding resulted in renal failure in db/db mice and 17-
DMAG treatment effectively preserved renal functions.
17-DMAG mitigates HFD-induced structural damage of
glomeruli and tubules
The effect of HFD and treatment with 17-DMAG on kidney
structure was examined with histopathology. The kidney samples
were collected at the time of renal failure (as indicated by oliguria,
anuria,and mortality) orattheend of the experiments(Day33of the
second phase HFD feeding after total mortality was observed in
saline-injected group of db/db mice) and analyzed by histopatho-
logical stains. Inspection of hematoxylin-eosin staining indicated
segmental glomerulosclerosis, patches of tubular vacuolation,
atrophy and degeneration in saline-injected db/db mice (db/db-
HF-S group, Figure 2 C and E). These damages induced by HFD in
the glomeruli and tubules were largely protected by 17-DMAG (db/
db-HF-Ggroup,Figure 2D and F).Inparallel experiments,HFD-fed
db/+ mice treated with saline (Figure 2 A) or 17-DMAG (Figure 2 B)
did not exhibit any glomerular and tubular abnormalities. Structural
damages in the db/db mice kidney was further confirmed by
mesangial matrix expansion and tubulointerstitial fibrosis in PAS
and Masson’s trichrome stained sections (Figure 2 G and I).
Interestingly, 17-DMAG treatment effectively ameliorated these
abnormalities (Figure 2 H and J). Quantification with morphometric
measurements confirmed significant alleviation of tubular damage
(Figure 2 K), mesangial matrix expansion (Figure 2 L), and collagen
accumulation (Figure 2 M) by 17-DMAG treatment.
High fat diet causes early death of db/db mice and 17-
DMAG treatment improves animal survival
Renal failure is expected to cause mortality in the absence of
additionaltreatments suchasdialysisorkidney transplantation.Our
results indicated that oliguria and anuria in HFD- fed db/db mice
were associated with early mortality. As demonstrated in Figure 3,
the earliest death among db/db mice injected with saline was
17-DMAG Ameliorates Renal Failure in Diabetes
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e32746observed on the 17
th day of second phase HFD challenge and
complete mortality was observed within 33 days. Treatment with
17-DMAG resulted in a significantly longer survival (db/db-HF-S vs
db/db-HF-G, Figure 3). It is noteworthy that the second phase HFD
feedingfor4–5 weeksdidnot causerenalfailureormortalityindb/+
mice regardless of saline or 17-DMAG treatments (Figure 3).
17-DMAG inhibits calcium efflux from the kidney
mitochondrial of HFD-fed db/db mice
Elevated fatty acids, particularly LA and other PUFA, in
diabetes may alter mitochondrial functions and ROS generation
by [Ca
2+]m efflux. Treatment of cells with 17-DMAG downreg-
ulates hsp90b1 and inhibits LA-induced [Ca
2+]m efflux [25,26].
Figure 1. Effects of high fat diet (HFD) and 17-DMAG treatment on kidney function of db/db mice. (A) Schematic of two phases of HFD
feeding and 17-DMAG treatment with the arrows indicating the scheduled kidney function assessments. During the first phase of HFD and the
subsequent regular diet(RD) feeding, the 24 h urinaryalbumin excretion(B) andurineoutput (C) were measuredtoassesskidney functions indb/db and
thenon-diabeticcontrol(db/+)mice.DuringthesecondphaseofHFDfeeding,theanimalswereeitherinjectedwithsaline(HF-S)or17-DMAG(HF-G)and
the kidney functions were initiallyassessedby the24 h urinary albumin excretion(D) andurineoutput (E), andthen byserum creatinine (G) when anuria
or oliguria occurred. Blood glucose was measured as indicated in (F).* * P,0.01, compared with baseline assessed on day 0 with n=6–12 per group.
doi:10.1371/journal.pone.0032746.g001
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HFD-fed db/db mice involved the regulation of the same
pathways in the kidney. Hsp90b1 levels in the kidney of HFD-
fed db/db mice was analyzed by immunoblotting and the results
demonstrated similar hsp90b1 levels in the kidney homogenates
and isolated mitochondria in animals treated with or without 17-
DMAG (db/db-HF-S vs db/db-HF-G, Figure 4 A and B).
Interestingly, as shown in Figure 4 C–E, LA-induced [Ca
2+]m
efflux was significantly diminished in the kidney mitochondria of
db/db mice treated with 17-DMAG compared to saline. Both the
rate and amplitude of LA-induced [Ca
2+]m efflux were signifi-
cantly attenuated by 17-DMAG treatment (Figure 4 D and E).
Figure 2. Kidney histopathology of HFD-fed db/db mice. Representative figures showing the photomicrographs of HE (A–F), PAS (G, H), and
Masson’s trichrome stained sections from db/db-HF-S group (C, E, G, I) and db/db-HF-G group (D, F, H, J) taken at 2006magnification. Image-based
computer assisted analysis was performed to quantify tubular damage index (K), mesangial expansion (L), and interstitial collagen accumulation (M)
from 6 animals per group. (A) and (B) showed parallel experiments with HFD-fed db/+ mice injected with saline and 17-DMAG, respectively.
doi:10.1371/journal.pone.0032746.g002
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the db/db-HF-G group even though the results did not reach
statistical significance (Figure 4 F). These data demonstrate that in
HFD-fed db/db mice, 17-DMAG reduces LA-induced [Ca
2+]m
efflux, which may preserve Ca
2+-dependent mitochondrial func-
tions and reduce oxidative stress in the kidney.
17-DMAG reduces nitrotyrosine level in HFD-fed db/db
mice kidney
Since LA-induced [Ca
2+]m efflux is coupled to peroxynitrite
generation [25] and nitrotyrosine level indicates oxidative damage
by peroxynitrite, we measured nitrotyrosine levels in kidney tissues
by immunoblotting and immunohistochemistry (Figure 5). As
demonstrated in Figure 5 A, nitrotyrosine level in proteins with
molecular weight #50 kDa was significantly higher in HFD-fed
db/db mice injected with saline than in db/+ mice. Interestingly,
17-DMAG treatment significantly lowered renal tissue nitrotyr-
osine levels in HFD-fed db/db mice (Figure 5A), indicating a
protective effect against nitrosative injury by HFD. The results of
immunohistochemistry also indicated high nitrotyrosine levels in
HFD-fed db/db mice, particularly in the glomerular region, and
Figure 3. Effect of 17-DMAG on survival rate of HFD-fed db/db
mice. Kaplan-Meyer survival analysis was performed using the log-rank
statistics to measure the difference between the survival curves of db/
db-HF-S vs db/db-HF-G mice with n=9 per group. Parallel experiments
were performed with db/+ mice (db/+-HF-S and db/+-HF-G groups) and
no mortality was observed.
doi:10.1371/journal.pone.0032746.g003
Figure 4. Impact of 17-DMAG on hsp90b1, [Ca
2+]m, and peroxynitrite generation in the kidney. Western blot analysis was performed to
assess hsp90b1 in kidney homogenate (A) and isolated mitochondria (B) of HFD-fed db/db mice with 6 animals per group. Linoleic acid (LA)-induced
[Ca
2+]m efflux and peroxynitrite generation (C–F) in kidney mitochondria were measured.
doi:10.1371/journal.pone.0032746.g004
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levels (Figure 5 B–D).
Discussion
Diabetic renal disease is a complication that develops in a
subpopulation of patients with longstanding diabetes [1]. The
deterioration in kidney functions including albuminuria and
reduction of glomerular filtration rate is associated with histo-
pathological alterations characterized by mesangial matrix expan-
sion, glomerulosclerosis and tubulointerstitial fibrosis [27]. All of
these functional and histopathological changes are believed to be
the result of an interaction between metabolic abnormality and
genetic predisposition [28]. Our results provide evidence that
HFD accelerates diabetic nephropathy and caused renal failure in
db/db mice, a rodent model of type 2 diabetes (Figures 1, 2, 3).
The exacerbated albuminuria but not the 24 h urine output
caused by HFD was reversible following discontinuation of HFD
(Figure 1). However, prolonged HFD feeding leads to oliguria and
anuria, an indication of renal failure, associated with animal death
in db/db mice. More severe damage to glomeruli and tubules was
also observed in HFD-fed db/db mice (Figure 2). All these
deleterious effects of HFD in db/db mice were significantly
ameliorated by inhibition of hsp90 with 17-DMAG. Our results
suggest that HFD may worsen diabetic nephropathy and cause
renal failure by exacerbating the metabolic abnormality in db/db
mice.
The levels of plasma glucose and nonesterified fatty acids
(NEFA) are elevated in type 2 diabetes and are implicated in
diabetic complications. Several clinical studies with large cohorts
have shown the role of hyperglycemia as a causative factor in the
development and progression of diabetic nephropathy [29–31].
Experimental evidence support that hyperglycemia alters the
expression of a number of genes involved in matrix protein
synthesis and degradation in the diabetic kidney [32]. Neverthe-
less, hyperglycemia alone is clearly not sufficient to account for the
heterogeneity and variability of diabetic nephropathy. We thus
used HFD-fed db/db mice to investigate the effect of high lipid
ingestion on the progression of diabetic nephropathy. We found
that following 2 weeks of HFD feeding, both db/+ and db/db
mice exerted excessive accumulation of adipose tissues as indicated
by the rapid extra bodyweight gains (11.5% in db/+ and 22% in
db/db on HFD, P,0.05, n=5), which were coupled with
significantly increased albuminuria in the kidney of db/db mice.
Both dietary lipid ingestion and deregulated lipolysis due to insulin
resistance may lead to higher circulated NEFA in HFD-fed db/db
mice. These observations suggest that the deleterious effect of
HFD on the kidney of db/db mice may be due to the exacerbating
metabolic abnormality associated with excessive fat accumulation
and elevated NEFA.
Kidney mitochondria, the major site of catabolism and
oxidation of carbohydrates and lipids, are readily exposed and
vulnerable to damaging insults from the exacerbated hyperglyce-
mia and hyperlipidemia in HFD-fed db/db mice and the damage
to renal mitochondria may contribute to worsening of nephrop-
athy and renal failure observed (Figures 1 and 2). Morphological
and ultrastructural changes of the mitochondria in proximal
tubules correlate with deterioration of renal function in diabetes
[33,34]. Increased posttranslational modification of renal mito-
chondrial proteins through glycation [35], nitration and oxidation
[36] is associated with the development of diabetic nephropathy in
animal models. Moreover, glycation of mitochondrial proteins is
associated with excess superoxide generation [35]. It has been
reported that repetitive intraperitoneal injection of NEFA-bond
bovine serum albumin leads to functional and structural
alterations in mouse kidney with characteristics similar to those
of diabetic nephropathy [37]. These renal abnormalities were
associated with a decrease in catalase, superoxide dismutase,
enzymes involved in NEFA oxidation, and antiapoptotic proteins,
and an increase of proinflammatory factors and macrophage
infiltration. We noted an imbalance in mitochondrial complex I
and III in the renal mitochondria in db/db mice [38,39]. In
Figure 5. Effect of 17-DMAG on nitrotyrosine levels in the kidney. (A) Western blot analysis of nitrotyrosine was performed with monoclonal
antibodies in kidney homogenates. The bar graphs were mean6SE density values from proteins #50 kDa normalized to the db/db-HF-S group from 6
animals per group. The nitrotyrosine level in kidney sections of db/+ (C), db/db-HF-S (D) and db/db-HF-G (E) groups was assessed by
immunohistochemistry with same monoclonal antibodies.
doi:10.1371/journal.pone.0032746.g005
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cause loss of mitochondrial membrane potential, activation of
caspase 3, 7, and 9, cytochrome c release and apoptosis, [Ca
2+]m
efflux and peroxynitrite generation [25,40]. We provided evidence
that the last action of NEFA is mediated by hsp90b1 [26]. It is
possible that all these NEFA actions upon mitochondria may
contribute to the deterioration of diabetic kidney and development
of renal failure in HFD-fed db/db mice. The beneficial effect of
17-DMAG on renal function and structure and the counteraction
of 17-DMAG upon linoleic acid induced [Ca
2+]m efflux in renal
mitochondria in HFD-fed db/db mice suggest the involvement of
these pathways.
As a highly water soluble derivative of geldanamycin, 17-
DMAG is an hsp90 inhibitor with potent anticancer activities
against a wide range of malignancies. Its application has been
expanded to treat a mouse model of spinal and bulbar muscular
atrophy [41]. In this study, treatment of db/db mice with 17-
DMAG during HFD challenge preserves renal function and
ameliorates damages to glomeruli and tubules, indicating involve-
ment of hsp90b1 in the pathology of diabetic nephropathy and
renal failure. As a chaperone protein, hsp90b1 is abundantly
expressed in cells and tissues and is widely distributed in most
subcellular organelles, such as plasma membrane, cytosol,
endoplasmic reticulum, mitochondrion, and nucleus [26,42–44].
Hsp90 were detected in outer medulla and glomeruli of rat kidney,
but no significant alterations were observed in type 1 diabetic rats
[45]. Increased hsp90b levels have been observed in muscles of
type 2 diabetes patients [46]. Our previous in vitro studies have
indicated that mitochondrial hsp90b1 is involved in regulating
cytosolic Ca
2+ and [Ca
2+]m homeostasis [24–26]. A major role of
[Ca
2+]m is to stimulate oxidative phosphorylation by activation of
multiple dehydrogenases [47] and ATP synthesis [48]. [Ca
2+]m
inhibits the generation of ROS from complexes I and III under
normal conditions whereas its overload promotes ROS generation
and apoptosis [49]. The enhanced [Ca
2+]m efflux in renal
mitochondria of HFD-fed db/db mice may diminish the inhibitory
effect of [Ca
2+]m on ROS production and thus leads to
overproduction of superoxide and peroxynitrite. Furthermore,
elevated NEFA, particularly linoleic acid, may augment the
interaction with hsp90b1 and [Ca
2+]m efflux to deplete [Ca
2+]m
and overproduce peroxynitrite, which exaggerates kidney oxida-
tive/nitrosative injuries and eventuates renal failure. This
paradigm is supported by the facts that enhanced [Ca
2+]m efflux
and nitrotyrosine levels were found in the kidney of HFD-fed db/
db mice and inhibition of hsp90 with 17-DMAG ameliorated these
HFD effects (Figures 4 and 5). The significant elevation of plasma
linoleic acids and arachidonic acids [50,51] and kidney nitrotyr-
osine levels [5,52,53] in type 2 diabetes patients indicate that a
similar scenario may also occur in human beings.
Although 17-DMAG effectively reduced [Ca
2+]m efflux and
nitrotyrosine levels in the kidney of HFD-fed db/db mice, we did
not observe a significant reduction in the peroxynitrite generation
coupled to linoleic acid-induced [Ca
2+]m efflux (Figures 4 and 5).
The reason for the different responses to hsp90 inhibition with
17-DMAG on peroxynitrite generation in mitochondria from db/
db mice and cultured human mesangial cells [25] is currently
unclear. Whether mitochondria in different cell types of kidney
(predominantly epithelial cells with few other cell types including
mesangial cells) respond to 17-DMAG distinctly requires further
investigations.
In summary, our results indicate that HFD aggravates
nephropathy and causes renal failure in diabetes and these effects
of HFD are antagonized by 17-DMAG. Decreased [Ca
2+]m efflux
and lowered nitrotyrosine levels may account for the beneficial
effect of 17-DMAG in diminishing nitrosative injury, preserving
kidney function and structure, and improving animal survival.
These results suggest that hsp90b1 is a potential target for
prevention or treatment of nephropathy and renal failure in
diabetes. 17-DMAG or other hsp90 inhibitors might represent
new and promising therapeutic candidates for diabetic nephrop-
athy and renal failure.
Materials and Methods
Animals
The animal protocols were approved by the Institutional
Animal Care and Use Committee, South Texas Veterans Health
Care System. Male db/db (BKS.Cg-m+/+Lepr
db/J), age and sex
matched db/+ mice were acquired from Jackson Laboratories at
age of 10 weeks and housed 4/cage or less. Animals were habitat
for 2 weeks in a temperature- and humidity-controlled facility with
a 12:12-h light-dark cycle, fed ad libitum with regular diet (7012
Teklad LM-485, Harlan Laboratories) and had free access to
water. The mice were challenged with high fat diet (HFD)
(TD.06414, Harlan Laboratories, 60.3% calories from fat) starting
at 12 weeks of age as depicted in Figure 1A. The HFD challenge
was divided into two phases: in the first phase the mice were fed
with HFD for 2 weeks followed by a 4-week regular diet period.
The second phase of HFD feeding was started after the 4-week
regular diet interval and continued for 5 weeks because of a total
mortality in HFD-fed db/db mice. At the beginning of the second
HFD feeding, db/db mice were randomly assigned to 2 groups and
intraperitoneally injected with either saline (vehicle, db/db-HF-S)
or 17-DMAG (6.5 mg/kg bodyweight, db/db-HF-G; InvivoGen).
Bodyweight of the animals was followed weekly and the dose of 17-
DMAG was adjusted according to bodyweight gains.
Assessment of renal function by 24-h urine output and
urinary albumin or serum creatinine
Urine collection and other physical parameters were measured
following the schedule in Figure 1A. The animals were fasted for
6 h (9:00 AM-3:00 PM) prior to blood glucose measurement with
a glucometer (Accu-Chek, Roche). 24 h urine samples were
collected from individual mice housed in metabolic cages and the
total urine volume was measured to index urine output. Urinary
albumin concentrations were determined using a murine albumin
ELISA kit (Albuwell M Kit; Exocell, Philadelphia, PA). In mice
with oliguria or anuria, serum creatinine concentrations were
determined by the Creatinine Companion kit (Exocell) to indicate
renal functions.
Histopathology
Formalin-fixed, paraffin-embedded kidney sections were stained
with haematoxylin and eosin (HE), periodic acid-Schiff (PAS), or
Masson’s trichrome and analyzed to evaluate kidney damages in a
blinded manner. The area of glomerular PAS staining was
measured by image analysis using Image-Pro Plus 4.5 (Media
Cybernetics, Silverspring, MD) as described [54]. A semi-
quantitative assessment was performed [55] in HE-stained slides
to evaluate the extent of tubular damage and graded from 1 to 5 as
follows: 1: vacuolation of cytoplasm in ,20% of tubules; 2:
vacuoles in 20% to 40% of tubules; 3: vacuoles in 40% to 60%
tubules with minimal distortion of tubular structures; 4: vacuoles in
60% to 80% of tubules with large and marked distortion of tubular
profiles, pyknotic nuclei, patches of tubular atrophy and tubular
degeneration; and 5: .80% of tubules with severe vacuolation, or
tubular atrophy and degeneration. The fractal collagen volume
17-DMAG Ameliorates Renal Failure in Diabetes
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quantify the blue stain in the trichrome-stained sections [56].
Measurement of [Ca
2+]m and peroxynitrite in
mitochondria
Kidney mitochondria were prepared from mice and LA-
induced [Ca
2+]m efflux and peroxynitrite generation were assessed
as previously described [25,26]. Briefly, fresh kidney tissues (0.1–
0.2 g) were homogenized in 5–10 ml MB1 solution containing
250 mM mannitol, 75 mM succinic acid, 0.1 mM EDTA,
0.5 mM EGTA, 10 mM HEPES, pH 7.4 at 4uC. The homoge-
nates were centrifuged at 329 g for 15 min and mitochondria in
the supernatant were collected by further centrifugation at
10000 g for 30 min. Mitochondria were double labeled with X-
rhod-1 AM (2 mM) and 29,79-dichlorodihydrofluorescein diacetate
(1 mM) at 37uC for 60 min and LA-induced [Ca
2+]m efflux and
peroxynitrite generation were measured by changes in X-rhod-1
and 29,79-dichlorodihydrofluorescein fluorescence, respectively
[25].
Assessment of hsp90b1 and nitrotyrosine
Immunoblotting and immunochemistry were performed to
detect hsp90b1 and nitrotyrosine levels. In immunoblotting
experiments, total and mitochondrial protein were isolated from
mice kidney as previously described [25]. The primary antibodies
used were as follows: mAb anti-mouse nitrotyrosine (1:1000, clone
1A6, Millipore); pAb anti-mouse GRP94 (1:1000, Santa Cruz
Biotechnology), mAb anti-mitochondrial complex 1 NDUFS-3
subunit (1:2000, Invitrogen) and mAb anti-a-tubulin (1:1000,
Invitrogen). The secondary antibodies were HRP-linked anti-
rabbit or anti-mouse IgG (1:5000, GE Healthcare UK Limited).
For the immunochemistry staining with mouse mAb, a specific
procedure was performed as previously described [57] to eliminate
the direct interaction between antigen and secondary antibody.
Prior to application to the specimen, the primary mAb was
incubated with secondary biotinylated anti-mouse immunoglobu-
lin, resulting in the binding of biotinylated secondary antibody to
the primary mAb. Normal mouse serum was added to the mixture
to bind the residual biotinylated anti-mouse immunoglobulin,
preventing the potential interaction with endogenous immuno-
globulin in the specimen. The nitrotyrosine levels were detected by
streptavidine-peroxidase (Dako ARK Kit) and peroxidase sub-
strate solution (DAB Substrate Kit, Vector Laboratories).
Statistical analysis
Results presented as mean6S.E and Student’s t-test was used to
evaluate the differences between two groups. Kaplan-Meyer
survival analysis was performed using the log-rank statistic to test
for a significant difference among the survival curves. Differences
were considered statistically significant at P,0.05.
Supporting Information
Figure S1 Effects of HFD and 17-DMAG treatment on
bodyweight and blood glucose levels of db/db mice.
HFD caused rapid gains in bodyweight that was reversed to the
baseline values measured prior to HFD feeding following four
weeks discontinuation of HFD. The elevation of blood glucose
after first HF seemed irreversible even after four weeks on RD
feeding. The bodyweight gain was significantly potentiated in db/
db-HF-D group compared to db/db-HF-S group (Figure S1). The
persistently elevated blood glucose level that were not reversed
during the four week interval of RD did not show further
significant increases in the second HFD challenge (Figure S1, right
panels). *P,0.05, **P,0.001, compared to baseline values
assessed on day 0 from 6–12 animals per group.
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